Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

NCT: NCT06790355 · COMPLETED

NCT IDNCT06790355
StatusCOMPLETED
Start Date2025-03-01
Completion2026-08-31
SponsorShanghai Weihe Medical Laboratory Co., Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-centre interventional study evaluating the feasibility of blood-based multi-cancer early detection test in asymptomatic screening cohort.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑